621 related articles for article (PubMed ID: 15767399)
1. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
2. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
[TBL] [Abstract][Full Text] [Related]
4. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
5. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.
Vilasco M; Larrea E; Vitour D; Dabo S; Breiman A; Regnault B; Riezu JI; Eid P; Prieto J; Meurs EF
Hepatology; 2006 Dec; 44(6):1635-47. PubMed ID: 17133498
[TBL] [Abstract][Full Text] [Related]
6. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
[TBL] [Abstract][Full Text] [Related]
7. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
[TBL] [Abstract][Full Text] [Related]
9. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
11. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions.
Kaukinen P; Sillanpää M; Nousiainen L; Melén K; Julkunen I
J Med Virol; 2013 Jan; 85(1):71-82. PubMed ID: 23096996
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.
Otsuka M; Kato N; Moriyama M; Taniguchi H; Wang Y; Dharel N; Kawabe T; Omata M
Hepatology; 2005 May; 41(5):1004-12. PubMed ID: 15841462
[TBL] [Abstract][Full Text] [Related]
16. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.
Li K; Foy E; Ferreon JC; Nakamura M; Ferreon AC; Ikeda M; Ray SC; Gale M; Lemon SM
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2992-7. PubMed ID: 15710891
[TBL] [Abstract][Full Text] [Related]
17. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
Binder M; Kochs G; Bartenschlager R; Lohmann V
Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
[TBL] [Abstract][Full Text] [Related]
19. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
20. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.
Foy E; Li K; Sumpter R; Loo YM; Johnson CL; Wang C; Fish PM; Yoneyama M; Fujita T; Lemon SM; Gale M
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2986-91. PubMed ID: 15710892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]